Clinical Trials Directory

Trials / Conditions / WHO Grade 3 Glioma

WHO Grade 3 Glioma

8 registered clinical trials studyying WHO Grade 3 Glioma — 3 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingStudy of Tovorafenib in High-Grade Glioma and Diffuse Intrinsic Pontine Glioma (DIPG)
NCT07206849
Nationwide Children's HospitalPhase 2
RecruitingAn Investigational Scan (Ga-68 PSMA-11 PET/CT) for Detection of Disease Recurrence or Progression in Patients
NCT06444412
Mayo ClinicPhase 2
RecruitingAnti-GARP Chimeric Antigen Receptor T Cell Therapy for the Treatment of Recurrent Grade III or IV Gliomas
NCT06964737
Ohio State University Comprehensive Cancer CenterPhase 1
TerminatedPerampanel for the Reduction of Seizure Frequency in Patients With High-grade Glioma and Focal Epilepsy
NCT04650204
Mayo ClinicPhase 4
Active Not RecruitingDabrafenib Combined With Trametinib After Radiation Therapy in Treating Patients With Newly-Diagnosed High-Gra
NCT03919071
National Cancer Institute (NCI)Phase 2
Active Not RecruitingOlaparib in Treating Patients With Advanced Glioma, Cholangiocarcinoma, or Solid Tumors With IDH1 or IDH2 Muta
NCT03212274
National Cancer Institute (NCI)Phase 2
Active Not RecruitingProton Beam or Intensity-Modulated Radiation Therapy in Preserving Brain Function in Patients With IDH Mutant
NCT03180502
NRG OncologyPhase 2
CompletedSelinexor in Treating Younger Patients With Recurrent or Refractory Solid Tumors or High-Grade Gliomas
NCT02323880
Children's Oncology GroupPhase 1